| |
 |
|
Leo Shunyakov, MD
 |
| Medical
Oncology |
|
|
|
|
Medical Education
|
|
7/2002-7/2005
|
Hematology/Oncology Fellow, University of Rochester |
|
7/1999-7/2002
|
University of Rochester/ Rochester General Internal Medicine Program, Rochester, NY |
|
7/1997-7/1998
|
USMLE-based self-education through the Grant for Medical Education for Urals Medical Academy/University of Rochester |
|
7/1996-7/1997
|
Internship, Urals Medical Academy, Yekaterinburg, Russia |
|
2/1996-5/1996
|
Exchange Student to the University of Rochester School of Medicine and Dentistry: Clinical Clerkship in Internal Medicine,
Hematology |
|
6/1990-6/1996
|
Urals Medical Academy (Combined Undergraduate and Graduate degree), Yekaterinburg, Russia |
|
|
|
|
Certifications and Exams
|
|
7/2006
|
Certified by the American Board of Internal Medicine in both Medical Oncology and Hematology |
|
8/2003, 9/2004
|
Spanish for Healthcare Professionals |
|
5/2003
|
Human Subject Protection Program Certificate (for Investigators) |
|
8/2002
|
American Board of Internal Medicine, Score 9/10 |
|
11/2001
|
USMLE Step III |
|
5/1998
|
ECFMG |
|
3/1998
|
USMLE Step II |
|
3/1997
|
USMLE Step I |
|
|
|
|
Employment
|
|
7/1997-7/1998
|
Internist, City Hospital No. 40, Yekaterinburg, Russia |
|
|
|
|
Research
|
|
2003-current
|
CLAG/ Gleevec regimen for treatment of early relapsed or refractory AML. Phase I/II clinical trial with in vitro correlative studies.
Co-Investigator. Principal Investigator: Professor Camille Abboud |
|
2001-2002
|
Bone Marrow Transplantation in Multiple Myeloma: Advantage of High Dose Therapy Over Conventional Treatment. ( Results of the University of Rochester Cancer Center experience 1993-2000.) Chart review, with Dr. Jane Liesveld, Director of BMT Unit, Strong Memorial Hospital, Rochester. |
|
10/1994-4/1995
|
Early Detection of the Minimal Residual Disease with PCR for bcr/abl in Children s/p Chemotherapy for Chronic Myelogenous Leukemia. Principal Investigator. Done with Dr. Alexander Sergeev, Professor of Medicine. Regional Pediatric Hospital, Yekaterinburg, Russia. |
|
|
|
|
Publications
|
|
|
Leo Shunyakov, Charlotte Ryan, Deepak Sahasrabudhe,Alok Khorana
The Influence of Host Response on Colorectal Cancer Prognosis.
Clinical Colorectal Cancer, Vol. 4, Issue 1, May 2004 |
|
|
Rami Komrokji, Leonid Shunyakov, Camille N Abboud, Gordon Phillips II. Reduced Intensity Allogeneic Stem Cell Transplant Using CLAG-Gleevec (Imatinib Mesylate) as Preparative Regimen for the Treatment of Acute Myeloid Leukemia Relapse after First Allogeneic Stem Cell Transplant: A Report of 3 Cases. Abstract #5556 Blood, Volume 102, issue 11, November 16, 2003 |
|
|
Leo Shunyakov, Gary H. Lyman
A Young Patient with Recently Diagnosed Breast Cancer Receiving Neoadjuvant Dose-Dense Chemotherapy With Pegfilgrastim Support.
Case Studies in Supportive Care, July 2003, Vol.2 No 1 |
|
|
Leonid Shunyakov, High Dose Therapy for Multiple Myeloma. Data of Single Institution Experience, 1992-2001. University of Rochester/ RGH Projects 2002 |
|
|
|
|
Honors and Awards
|
|
2004-2005
|
Chief Hematology/Oncology Fellow |
|
2004
|
Aventis Fellowship for the year 2004/2005 |
|
03/2003
|
Nominated for NCCN guidelines conference. Certificate of Excellence. |
|
2/1996-6/1996
|
Exchange Clerkship Scholar to the University of Rochester School of Medicine and Dentistry. Awarded for excellence in Medicine. One of 5 awarded in a Class of 350. |
|
1995-1996
|
Chairman of the Student Scientific Society, Urals Medical Academy. |
|
1993-1996
|
Class Vice President, Urals Medical Academy, Yekaterinburg, Russia. |
|
1990-1996
|
Academic Scholarship to Medical School each year. |
|
|
SubCategory Description
|
|
|
|
|
Professional Memberships
|
|
|
American Society of Clinical Oncology |
|
|
American Medical Association |
|
|
|
|
Presentations, University of Rochester
|
|
|
Carcinomatous meningitis |
|
|
Microsatellite instability and colon cancer |
|
|
Adjuvant therapy of stage II colon cancer |
|
|
Pemetrexed and Docetaxel in recurrent lung cancer |
|
|
Adjuvant therapy of early breast cancer |
|
|
Antiphospholipid syndrome, pathogenesis and therapy |
|
|
Hypereosinophylia, PDGFR-beta and Gleevec |
|
|
HHV-8 as a cause of Kaposi's and other diseases |
|
|
Cryoglobulinemic vasculitis - pathogenesis and therapy |
|
|
Homocysteine, endothelial dysfunction and aortic aneurysm |
|
|
POEMS, HHV-8 and VEGF |
|
|
PLL and mantle cell leukemia |
|
|
Hematologic Emergencies |
|
|
Oncologic Emergencies |
|
|
|
|
Additional subspecialty training
|
|
|
Non-Hodgkin's and Hodgkin's lymphomas |
|
|
Bone marrow transplantation |
|
|
Gynecologic Oncology |
|
|
Neuro-oncology |
|
|
Hematopathology |
|
|
|
|
References
|
|
Deepak Sahasrabudhe, MD
|
Program Director, Hematology/ Oncology Fellowship
|
|
|
James P. Wilmot Cancer Center
Strong Memorial Hospital, University of Rochester
601 Elmwood Avenue, Box 704, Rochester, NY 14642
Phone 585-275-4797
deepak_sahasrabudhe@urmc.rochester.edu |
|
Gordon Phillips, MD
|
Bone Marrow Transplant Director James P Wilmot Cancer Center
|
|
|
Strong Memorial Hospital, University of Rochester
601 Elmwood Avenue, Box 704, Rochester, NY 14642
karen_kaplan@urmc.rochester.edu |
|
Camille N Abboud, MD
|
Professor of Medicine |
|
|
James P Wilmot Cancer Center
Strong Memorial Hospital, University of Rochester
601 Elmwood Avenue, Box 704, Rochester, NY 14642
camille_abboud@urmc.rochester.edu |
|
Jane Liesveld, MD
|
|
|
|
James P Wilmot Cancer Center
Strong Memorial Hospital, University of Rochester
601 Elmwood Avenue, Box 704, Rochester, NY 14642
jane_liesveld @urmc.rochester.edu |
|
|
|
